Logo image of PYCR

PAYCOR HCM INC (PYCR) Stock Fundamental Analysis

NASDAQ:PYCR - Nasdaq - US70435P1021 - Common Stock

22.1  +0.01 (+0.05%)

After market: 22.1699 +0.07 (+0.32%)

Fundamental Rating

3

Overall PYCR gets a fundamental rating of 3 out of 10. We evaluated PYCR against 82 industry peers in the Professional Services industry. PYCR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, PYCR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PYCR had positive earnings in the past year.
In the past year PYCR had a positive cash flow from operations.
In the past 5 years PYCR always reported negative net income.
Each year in the past 5 years PYCR had a positive operating cash flow.
PYCR Yearly Net Income VS EBIT VS OCF VS FCFPYCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of PYCR (-1.87%) is worse than 70.89% of its industry peers.
PYCR's Return On Equity of -3.51% is on the low side compared to the rest of the industry. PYCR is outperformed by 72.15% of its industry peers.
Industry RankSector Rank
ROA -1.87%
ROE -3.51%
ROIC N/A
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
PYCR Yearly ROA, ROE, ROICPYCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -2 -4 -6 -8 -10

1.3 Margins

With a decent Gross Margin value of 65.96%, PYCR is doing good in the industry, outperforming 77.22% of the companies in the same industry.
In the last couple of years the Gross Margin of PYCR has remained more or less at the same level.
PYCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
PYCR Yearly Profit, Operating, Gross MarginsPYCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

PYCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PYCR has been increased compared to 1 year ago.
Compared to 5 years ago, PYCR has more shares outstanding
PYCR has a worse debt/assets ratio than last year.
PYCR Yearly Shares OutstandingPYCR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PYCR Yearly Total Debt VS Total AssetsPYCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.07 indicates that PYCR is not a great score, but indicates only limited risk for bankruptcy at the moment.
PYCR has a Altman-Z score of 2.07. This is in the lower half of the industry: PYCR underperforms 65.82% of its industry peers.
PYCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.07
ROIC/WACCN/A
WACC9.25%
PYCR Yearly LT Debt VS Equity VS FCFPYCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PYCR has a Current Ratio of 1.15. This is a normal value and indicates that PYCR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.15, PYCR is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
PYCR has a Quick Ratio of 1.15. This is a normal value and indicates that PYCR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PYCR (1.15) is worse than 60.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
PYCR Yearly Current Assets VS Current LiabilitesPYCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.27% over the past year.
PYCR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.45%.
PYCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.57% yearly.
EPS 1Y (TTM)29.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%16.64%

3.2 Future

PYCR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.73% yearly.
Based on estimates for the next years, PYCR will show a quite strong growth in Revenue. The Revenue will grow by 12.95% on average per year.
EPS Next Y14.56%
EPS Next 2Y13.93%
EPS Next 3Y15.2%
EPS Next 5Y21.73%
Revenue Next Year12.2%
Revenue Next 2Y11.75%
Revenue Next 3Y12.1%
Revenue Next 5Y12.95%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PYCR Yearly Revenue VS EstimatesPYCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
PYCR Yearly EPS VS EstimatesPYCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 41.70, PYCR can be considered very expensive at the moment.
70.89% of the companies in the same industry are cheaper than PYCR, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.96, PYCR is valued a bit more expensive.
The Price/Forward Earnings ratio is 34.05, which means the current valuation is very expensive for PYCR.
PYCR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PYCR is more expensive than 67.09% of the companies in the same industry.
PYCR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41.7
Fwd PE 34.05
PYCR Price Earnings VS Forward Price EarningsPYCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PYCR indicates a slightly more expensive valuation: PYCR is more expensive than 75.95% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PYCR is valued a bit more expensive than the industry average as 65.82% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 88.89
EV/EBITDA 39.12
PYCR Per share dataPYCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PYCR does not grow enough to justify the current Price/Earnings ratio.
PYCR's earnings are expected to grow with 15.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.86
PEG (5Y)N/A
EPS Next 2Y13.93%
EPS Next 3Y15.2%

0

5. Dividend

5.1 Amount

No dividends for PYCR!.
Industry RankSector Rank
Dividend Yield N/A

PAYCOR HCM INC

NASDAQ:PYCR (1/17/2025, 8:23:05 PM)

After market: 22.1699 +0.07 (+0.32%)

22.1

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners43.22%
Inst Owner Change0.02%
Ins Owners1.22%
Ins Owner Change40.11%
Market Cap3.97B
Analysts76.52
Price Target22.12 (0.09%)
Short Float %5.24%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.2%
Min EPS beat(2)15.81%
Max EPS beat(2)28.59%
EPS beat(4)4
Avg EPS beat(4)17.62%
Min EPS beat(4)3.43%
Max EPS beat(4)28.59%
EPS beat(8)8
Avg EPS beat(8)27.49%
EPS beat(12)12
Avg EPS beat(12)35.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.24%
Max Revenue beat(2)1.24%
Revenue beat(4)3
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.24%
Revenue beat(8)7
Avg Revenue beat(8)0.71%
Revenue beat(12)11
Avg Revenue beat(12)1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.83%
PT rev (3m)19.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.76%
EPS NY rev (1m)0%
EPS NY rev (3m)4.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.07%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 41.7
Fwd PE 34.05
P/S 5.85
P/FCF 88.89
P/OCF 36.83
P/B 3.06
P/tB 12.62
EV/EBITDA 39.12
EPS(TTM)0.53
EY2.4%
EPS(NY)0.65
Fwd EY2.94%
FCF(TTM)0.25
FCFY1.12%
OCF(TTM)0.6
OCFY2.72%
SpS3.78
BVpS7.23
TBVpS1.75
PEG (NY)2.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.87%
ROE -3.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.96%
FCFM 6.58%
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.71%
Cap/Sales 9.3%
Interest Coverage N/A
Cash Conversion 108.91%
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 2.07
F-Score6
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)42.74%
Cap/Depr(5y)34.82%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y14.56%
EPS Next 2Y13.93%
EPS Next 3Y15.2%
EPS Next 5Y21.73%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%16.64%
Revenue Next Year12.2%
Revenue Next 2Y11.75%
Revenue Next 3Y12.1%
Revenue Next 5Y12.95%
EBIT growth 1Y51.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.66%
EBIT Next 3Y43.84%
EBIT Next 5YN/A
FCF growth 1Y245.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y516.08%
OCF growth 3Y102.92%
OCF growth 5YN/A